Patient Guide: A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 62 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06153238
Status: 🟢 Enrolling Now
Condition: Melanoma
Phase: PHASE1

Where You Can Participate

This study is available at 62 locations across the country.

Top locations include:
  • • Orange, California
  • • Clermont, Florida
  • • Orange City, Florida
  • • And 59 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma - Join Clinical Trial NCTNCT06153238

How to Join This Clinical Trial - NCTNCT06153238

Learn how to participate in this PHASE1 trial studying an investigational therapy for Melanoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06153238 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 62 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Clermont, Florida 34711 - United States

Status: RECRUITING

Clinical Research Site

Orange City, Florida 32763 - United States

Status: RECRUITING

Clinical Research Site

Banja Luka, - Bosnia and Herzegovina

Status: RECRUITING

Clinical Research Site

Mostar, - Bosnia and Herzegovina

Status: RECRUITING

Clinical Research Site

Sarajevo, - Bosnia and Herzegovina

Status: RECRUITING

Clinical Research Site

Tuzla, - Bosnia and Herzegovina

Status: RECRUITING

Clinical Research Site

Barretos, - Brazil

Status: RECRUITING

Clinical Research Site

Belo Horizonte, - Brazil

Status: RECRUITING

Clinical Research Site

Canoas, - Brazil

Status: RECRUITING

And 52 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships